# Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects

> **NCT05138770** · PHASE1 · COMPLETED · sponsor: **Jiangsu vcare pharmaceutical technology co., LTD** · enrollment: 78 (actual)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

- **DRUG:** VC005 Tablets
- **DRUG:** VC005 Tablets Placebo
- **DRUG:** VC005 Tablets food effects group

## Key facts

- **NCT ID:** NCT05138770
- **Lead sponsor:** Jiangsu vcare pharmaceutical technology co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-18
- **Primary completion:** 2022-08-26
- **Final completion:** 2022-08-30
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2022-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05138770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05138770, "Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05138770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*